Search

Search Constraints

You searched for: Author/Creator Grever, Michael R.

Search Results

11. Pharmacokinetics and dose escalation of the heat shock protein inhibitor 17-allyamino-17-demethoxygeldanamycin in combination with bortezomib in relapsed or refractory acute myeloid leukemia. Issue 9 (September 2013)

12. Phase I study of azacitidine and bortezomib in adults with relapsed or refractory acute myeloid leukemia. Issue 6 (June 2014)

13. Phase I study of GTI-2040, a ribonucleotide reductase antisense, with high dose cytarabine in patients with relapsed/refractory acute myeloid leukemia. Issue 6 (June 2014)

14. Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]‐Fluorothymidine Positron Emission Tomography Biomarker Study. (17th June 2020)

15. Population pharmacokinetics of lenalidomide in patients with B‐cell malignancies. Issue 5 (27th February 2019)

16. Reduced occurrence of tumor flare with flavopiridol followed by combined flavopiridol and lenalidomide in patients with relapsed chronic lymphocytic leukemia (CLL). Issue 4 (25th February 2015)

18. Trametinib for the treatment of IGHV4-34, MAP2K1-mutant variant hairy cell leukemia. Issue 4 (3rd April 2018)